NCT01266603
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
2,773 public trials
496 recruiting studies
Neuroendocrine Tumors trial results
NCT04274816
- Conditions
- Cutaneous Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
Not specified
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Hospital Universitario Donostia Donostia / San Sebastian, Guipuzcoa, Spain
- Hospital General Universitario Santa Lucía Cartagena, Murcia, Spain
- Hospital Clínic de Barcelona Barcelona, Spain
- Hospital del Mar Barcelona, Spain
NCT02608034
- Conditions
- Melanoma, Metastatic Melanoma, BRAF V600 Mutation Positive, Neoplasms, +10 more
- Locations
-
- Mary Crowley Medical Research Center Dallas, Texas, United States
- Rambam Health Care Campus; Oncology Haifa, Israel
- Hadassah Ein Karem Hospital; Oncology Dept Jerusalem, Israel
- Tel Aviv Sourasky Medical Center; Pharmacy Tel Aviv, Israel
NCT01941927
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT03052205
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale, Arizona, United States
- The University of Arizona Cancer Center Tucson, Arizona, United States
- University of California San Francisco (UCSF) San Francisco, California, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT02451488
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04253574
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
Not specified
NCT02537600
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
- Locations
-
- CHU de Bordeaux Bordeaux, France
- CHU Ambroise Paré Boulogne, France
- CHU Brest - Hôpital Morvan Brest, France
- CHU Caen - Hôpital Clémenceau Caen, France
Completed
Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer
NCT01065441
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +62 more
- Locations
-
- Hadassah-Hebrew University Medical Center Jerusalem, Israel